rmi 12330a has been researched along with itraconazole in 1 studies
Studies (rmi 12330a) | Trials (rmi 12330a) | Recent Studies (post-2010) (rmi 12330a) | Studies (itraconazole) | Trials (itraconazole) | Recent Studies (post-2010) (itraconazole) |
---|---|---|---|---|---|
141 | 0 | 24 | 6,440 | 653 | 2,357 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akula, I; Edlind, T; Jain, P | 1 |
1 other study(ies) available for rmi 12330a and itraconazole
Article | Year |
---|---|
Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Antifungal Agents; Azoles; Candida; Cyclic AMP; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genotype; Imines; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Naphthalenes; Protein Synthesis Inhibitors; Saccharomyces cerevisiae; Signal Transduction; Sterols; Terbinafine; Up-Regulation | 2003 |